Pfizer ’s CTI and ADDF to co-fund new project to treat neurodegenerative diseases

The Alzheimer ’s Drug Discovery Foundation (ADDF) and Pfizer’s Centers for Therapeutic Innovation (CTI) will jointly fund a new project that seeks to develop potential treatments for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news